Aso Y - Search Results

1

Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide).

Isurugi K, Niijima T, Akaza H, Aso Y, Koiso K, Fuse M, Okada K, Usami M, Ohashi T, Ueda T; TAP-144-SR Collaborative Study Group. Isurugi K, et al. Among authors: aso y. J Chemother. 1989 Jul;1(4 Suppl):1237-41. J Chemother. 1989. PMID: 16312848 No abstract available.

2

Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.

Akaza H, Usami M, Koiso K, Kotake T, Aso Y, Niijima T. Akaza H, et al. Among authors: aso y. Jpn J Clin Oncol. 1992 Jun;22(3):177-84. Jpn J Clin Oncol. 1992. PMID: 1518166

3

[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer].

Aso Y, Kameyama S, Niijima T, Ohmori H, Ohashi T, Murahashi I, Akimoto M, Koiso K, Akaza H, Hosaka M, et al. Aso Y, et al. Hinyokika Kiyo. 1991 Mar;37(3):305-20. Hinyokika Kiyo. 1991. PMID: 1906239 Free article. Clinical Trial. Japanese.

4

Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group.

Akaza H, Aso Y, Koiso K, Fuse H, Isurugi K, Okada K, Usami M, Kotake T, Ohashi T, Ueda T, et al. Akaza H, et al. Among authors: aso y. J Int Med Res. 1990;18 Suppl 1:90-102. doi: 10.1177/03000605900180S114. J Int Med Res. 1990. PMID: 2108889 Clinical Trial.

5

Recommended dose of flutamide with LH-RH agonist therapy in patients with advanced prostate cancer.

Akaza H, Isaka S, Usami M, Kanetake H, Kotake T, Koiso K, Aso Y. Akaza H, et al. Among authors: aso y. Int J Urol. 1996 Nov;3(6):468-71. doi: 10.1111/j.1442-2042.1996.tb00578.x. Int J Urol. 1996. PMID: 9170575 Free article. Clinical Trial.

6

Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2).

Akaza H, Fukushima H, Koiso K, Aso Y. Akaza H, et al. Among authors: aso y. Cancer. 1992 Feb 15;69(4):997-1002. doi: 10.1002/1097-0142(19920215)69:4<997::aid-cncr2820690428>3.0.co;2-u. Cancer. 1992. PMID: 1370920

7

Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group.

Aso Y, Akaza H. Aso Y, et al. J Urol. 1992 Apr;147(4):1060-4. doi: 10.1016/s0022-5347(17)37468-2. J Urol. 1992. PMID: 1372661

8

[Clinical study of RU 23908 (nilutamide) in prostatic cancer].

Akaza H, Aso Y, Niijima T, Fuse H, Izaka S, Akimoto S, Shimazaki J, Imai K, Yamanaka H, Kihara K, et al. Akaza H, et al. Among authors: aso y. Hinyokika Kiyo. 1991 Apr;37(4):407-20. Hinyokika Kiyo. 1991. PMID: 1892002 Free article. Clinical Trial. Japanese.

9

[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR].

Niijima T, Aso Y, Akaza H, Fujita K, Fuse H, Hosaka M, Isurugi K, Kamidono S, Katayama T, Kawabe K, et al. Niijima T, et al. Among authors: aso y. Hinyokika Kiyo. 1990 Nov;36(11):1343-60. Hinyokika Kiyo. 1990. PMID: 2126912 Free article. Japanese.

10

[Histological effects of endocrine therapy on prostatic cancer].

Isaka S, Akakura K, Shimazaki J, Kumamoto Y, Kubo T, Yamanaka H, Akaza H, Aso Y, Okada K, Baba S, et al. Isaka S, et al. Among authors: aso y. Nihon Hinyokika Gakkai Zasshi. 1990 Oct;81(10):1530-6. doi: 10.5980/jpnjurol1989.81.1530. Nihon Hinyokika Gakkai Zasshi. 1990. PMID: 2273705 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

900 results

Search Page

Filters